Thing 1/Thing 2: Republican Congressman Chris Collins reportedly took a nearly $17 million hit as the stock for Innate Immunotherapeutics, an Australian pharmaceutical company he sits on the board of and is the largest investor in, bottomed out.June 28, 2017